Cericlamine
Overview of the antidepressant drug Cericlamine
| Cericlamine | |
|---|---|
|
|
Cericlamine is a pharmaceutical compound that was investigated for its potential use as an antidepressant. It belongs to the class of drugs known as selective serotonin reuptake inhibitors (SSRIs), which are commonly used in the treatment of depression and other mood disorders.
Pharmacology[edit]
Cericlamine functions primarily by inhibiting the reuptake of serotonin, a neurotransmitter that plays a key role in mood regulation. By preventing the reabsorption of serotonin into the presynaptic neuron, cericlamine increases the availability of serotonin in the synaptic cleft, thereby enhancing serotonergic neurotransmission.
Mechanism of Action[edit]
The mechanism of action of cericlamine is similar to that of other SSRIs. It selectively binds to the serotonin transporter (SERT) on the presynaptic neuron, blocking the reuptake of serotonin. This leads to an increase in serotonin levels in the synaptic cleft, which is thought to contribute to its antidepressant effects.
Clinical Development[edit]
Cericlamine was developed and studied in clinical trials to assess its efficacy and safety as an antidepressant. However, it did not reach the market due to various factors, including the availability of other effective SSRIs and potential side effects observed during trials.
Side Effects[edit]
As with other SSRIs, cericlamine was associated with a range of side effects. Common side effects included nausea, headache, insomnia, and sexual dysfunction. These side effects are typical of SSRIs due to their action on serotonin levels in the brain.
Comparison with Other SSRIs[edit]
Cericlamine was compared to other SSRIs such as fluoxetine, sertraline, and paroxetine during its development. While it showed similar efficacy in increasing serotonin levels, its side effect profile and lack of significant advantages over existing medications limited its commercial development.
Related pages[edit]
Sponsored Health Resource
W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
